Variant report
Variant | nsv963874 |
---|---|
Chromosome Location | chr2:53132199-53140908 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MXI1 | chr2:53137866-53138008 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | NFYA | chr2:53138258-53138441 | GM12878 | blood: | n/a | n/a |
3 | NR2F2 | chr2:53131739-53132236 | MCF-7 | breast: | n/a | n/a |
4 | POLR2A | chr2:53137929-53137963 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | POLR2A | chr2:53139526-53139595 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | STAT3 | chr2:53137672-53137871 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | TCF7L2 | chr2:53132666-53132849 | HepG2 | liver: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:53132852..53133808-chr20:52198265..52198765,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ASB3-1 | chr2:53137102-53137158 | ENSG00000228033 |
2 | lnc-ASB3-1 | chr2:53137102-53137158 | ENSG00000228033 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000228033 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs367829588 | chr2:53132221-53132222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs183713487 | chr2:53132254-53132255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs79220149 | chr2:53132262-53132263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561839385 | chr2:53132263-53132264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148017531 | chr2:53132268-53132269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369278576 | chr2:53132269-53132270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs58012888 | chr2:53132294-53132295 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540136859 | chr2:53132305-53132306 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575375393 | chr2:53132314-53132315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546847096 | chr2:53132358-53132359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544115698 | chr2:53132368-53132369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564597405 | chr2:53132407-53132408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185522971 | chr2:53132412-53132413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs17571144 | chr2:53132416-53132417 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs537152065 | chr2:53132439-53132440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs17043766 | chr2:53132485-53132486 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs374202073 | chr2:53132489-53132490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190436561 | chr2:53132512-53132513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs569476845 | chr2:53132523-53132524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538419032 | chr2:53132531-53132532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551728053 | chr2:53132538-53132539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182258846 | chr2:53132539-53132540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539159352 | chr2:53132543-53132544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577162102 | chr2:53132631-53132632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186921902 | chr2:53132640-53132641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554737322 | chr2:53132650-53132651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545830010 | chr2:53132708-53132709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs367811803 | chr2:53132718-53132719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372670964 | chr2:53132720-53132721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575493585 | chr2:53132728-53132729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570708978 | chr2:53132768-53132769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs540363344 | chr2:53132792-53132793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553227606 | chr2:53132818-53132819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs578015654 | chr2:53132928-53132929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs193231460 | chr2:53132950-53132951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540346492 | chr2:53132958-53132959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs17043770 | chr2:53132960-53132961 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs537088233 | chr2:53132977-53132978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529225982 | chr2:53133004-53133005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542645632 | chr2:53133012-53133013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs55848819 | chr2:53133014-53133015 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs372254778 | chr2:53133027-53133028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556997726 | chr2:53133089-53133090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147259062 | chr2:53133105-53133106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551901941 | chr2:53133117-53133118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571754925 | chr2:53133131-53133132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114655230 | chr2:53133158-53133159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546697638 | chr2:53133190-53133191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs17043772 | chr2:53133224-53133225 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs535436178 | chr2:53133225-53133226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:53109400-53145600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:53131400-53132400 | Enhancers | Hela-S3 | cervix |